Selected research
Industry Research
CROs Services Industry Research Report 2026
Market perspective
The global CROs Services market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the CROs Services market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the CROs Services market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the CROs Services market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of CROs Services include IQVIA, Wuxi Apptec, Worldwide Clinical Trials, Syneos Health, PSI CRO, PROMETRIKA, Premier Research, PRA and PPD, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global CROs Services market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to CROs Services.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
CROs Services Market by Company
IQVIA
Wuxi Apptec
Worldwide Clinical Trials
Syneos Health
PSI CRO
PROMETRIKA
Premier Research
PRA
PPD
Pierrel Research
Parexel
Medpace
Labcorp
ICON
Hangzhou Tigermed
EPS International
Courante Oncology
CMIC
Clinipace
Charles River Laboratories International Inc (CRL)
CROs Services Segment by Type
Full-Service CRO
Functional Service Provision CRO
CROs Services Segment by Application
Pre-clinical
Clinical I-Ⅲ
Other
CROs Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global CROs Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of CROs Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of CROs Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of CROs Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Full-Service CRO
- Functional Service Provision CRO
Applications
- Pre-clinical
- Clinical I-Ⅲ
- Other
Companies covered
- IQVIA
- Wuxi Apptec
- Worldwide Clinical Trials
- Syneos Health
- PSI CRO
- PROMETRIKA
- Premier Research
- PRA
- PPD
- Pierrel Research
- Parexel
- Medpace
- Labcorp
- ICON
- Hangzhou Tigermed
- EPS International
- Courante Oncology
- CMIC
- Clinipace
- Charles River Laboratories International Inc (CRL)
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 CROs Services by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Full-Service CRO
- 2.2.3 Functional Service Provision CRO
- 2.3 CROs Services by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Pre-clinical
- 2.3.3 Clinical I-Ⅲ
- 2.3.4 Other
- 2.4 Assumptions and Limitations
3 CROs Services Breakdown Data by Type
- 3.1 Global CROs Services Historic Market Size by Type (2021-2026)
- 3.2 Global CROs Services Forecasted Market Size by Type (2027-2032)
4 CROs Services Breakdown Data by Application
- 4.1 Global CROs Services Historic Market Size by Application (2021-2026)
- 4.2 Global CROs Services Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global CROs Services Market Perspective (2021-2032)
- 5.2 Global CROs Services Growth Trends by Region
- 5.2.1 Global CROs Services Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 CROs Services Historic Market Size by Region (2021-2026)
- 5.2.3 CROs Services Forecasted Market Size by Region (2027-2032)
- 5.3 CROs Services Market Dynamics
- 5.3.1 CROs Services Industry Trends
- 5.3.2 CROs Services Market Drivers
- 5.3.3 CROs Services Market Challenges
- 5.3.4 CROs Services Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top CROs Services Players by Revenue
- 6.1.1 Global Top CROs Services Players by Revenue (2021-2026)
- 6.1.2 Global CROs Services Revenue Market Share by Players (2021-2026)
- 6.2 Global CROs Services Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of CROs Services Head Office and Area Served
- 6.4 Global CROs Services Players, Product Type & Application
- 6.5 Global CROs Services Manufacturers Established Date
- 6.6 Global CROs Services Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America CROs Services Market Size (2021-2032)
- 7.2 North America CROs Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America CROs Services Market Size by Country (2021-2026)
- 7.4 North America CROs Services Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe CROs Services Market Size (2021-2032)
- 8.2 Europe CROs Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe CROs Services Market Size by Country (2021-2026)
- 8.4 Europe CROs Services Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific CROs Services Market Size (2021-2032)
- 9.2 Asia-Pacific CROs Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific CROs Services Market Size by Country (2021-2026)
- 9.4 Asia-Pacific CROs Services Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America CROs Services Market Size (2021-2032)
- 10.2 South America CROs Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America CROs Services Market Size by Country (2021-2026)
- 10.4 South America CROs Services Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa CROs Services Market Size (2021-2032)
- 11.2 Middle East & Africa CROs Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa CROs Services Market Size by Country (2021-2026)
- 11.4 Middle East & Africa CROs Services Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 IQVIA
- 12.1.1 IQVIA Company Information
- 12.1.2 IQVIA Business Overview
- 12.1.3 IQVIA Revenue in CROs Services Business (2021-2026)
- 12.1.4 IQVIA CROs Services Product Portfolio
- 12.1.5 IQVIA Recent Developments
- 12.2 Wuxi Apptec
- 12.2.1 Wuxi Apptec Company Information
- 12.2.2 Wuxi Apptec Business Overview
- 12.2.3 Wuxi Apptec Revenue in CROs Services Business (2021-2026)
- 12.2.4 Wuxi Apptec CROs Services Product Portfolio
- 12.2.5 Wuxi Apptec Recent Developments
- 12.3 Worldwide Clinical Trials
- 12.3.1 Worldwide Clinical Trials Company Information
- 12.3.2 Worldwide Clinical Trials Business Overview
- 12.3.3 Worldwide Clinical Trials Revenue in CROs Services Business (2021-2026)
- 12.3.4 Worldwide Clinical Trials CROs Services Product Portfolio
- 12.3.5 Worldwide Clinical Trials Recent Developments
- 12.4 Syneos Health
- 12.4.1 Syneos Health Company Information
- 12.4.2 Syneos Health Business Overview
- 12.4.3 Syneos Health Revenue in CROs Services Business (2021-2026)
- 12.4.4 Syneos Health CROs Services Product Portfolio
- 12.4.5 Syneos Health Recent Developments
- 12.5 PSI CRO
- 12.5.1 PSI CRO Company Information
- 12.5.2 PSI CRO Business Overview
- 12.5.3 PSI CRO Revenue in CROs Services Business (2021-2026)
- 12.5.4 PSI CRO CROs Services Product Portfolio
- 12.5.5 PSI CRO Recent Developments
- 12.6 PROMETRIKA
- 12.6.1 PROMETRIKA Company Information
- 12.6.2 PROMETRIKA Business Overview
- 12.6.3 PROMETRIKA Revenue in CROs Services Business (2021-2026)
- 12.6.4 PROMETRIKA CROs Services Product Portfolio
- 12.6.5 PROMETRIKA Recent Developments
- 12.7 Premier Research
- 12.7.1 Premier Research Company Information
- 12.7.2 Premier Research Business Overview
- 12.7.3 Premier Research Revenue in CROs Services Business (2021-2026)
- 12.7.4 Premier Research CROs Services Product Portfolio
- 12.7.5 Premier Research Recent Developments
- 12.8 PRA
- 12.8.1 PRA Company Information
- 12.8.2 PRA Business Overview
- 12.8.3 PRA Revenue in CROs Services Business (2021-2026)
- 12.8.4 PRA CROs Services Product Portfolio
- 12.8.5 PRA Recent Developments
- 12.9 PPD
- 12.9.1 PPD Company Information
- 12.9.2 PPD Business Overview
- 12.9.3 PPD Revenue in CROs Services Business (2021-2026)
- 12.9.4 PPD CROs Services Product Portfolio
- 12.9.5 PPD Recent Developments
- 12.10 Pierrel Research
- 12.10.1 Pierrel Research Company Information
- 12.10.2 Pierrel Research Business Overview
- 12.10.3 Pierrel Research Revenue in CROs Services Business (2021-2026)
- 12.10.4 Pierrel Research CROs Services Product Portfolio
- 12.10.5 Pierrel Research Recent Developments
- 12.11 Parexel
- 12.11.1 Parexel Company Information
- 12.11.2 Parexel Business Overview
- 12.11.3 Parexel Revenue in CROs Services Business (2021-2026)
- 12.11.4 Parexel CROs Services Product Portfolio
- 12.11.5 Parexel Recent Developments
- 12.12 Medpace
- 12.12.1 Medpace Company Information
- 12.12.2 Medpace Business Overview
- 12.12.3 Medpace Revenue in CROs Services Business (2021-2026)
- 12.12.4 Medpace CROs Services Product Portfolio
- 12.12.5 Medpace Recent Developments
- 12.13 Labcorp
- 12.13.1 Labcorp Company Information
- 12.13.2 Labcorp Business Overview
- 12.13.3 Labcorp Revenue in CROs Services Business (2021-2026)
- 12.13.4 Labcorp CROs Services Product Portfolio
- 12.13.5 Labcorp Recent Developments
- 12.14 ICON
- 12.14.1 ICON Company Information
- 12.14.2 ICON Business Overview
- 12.14.3 ICON Revenue in CROs Services Business (2021-2026)
- 12.14.4 ICON CROs Services Product Portfolio
- 12.14.5 ICON Recent Developments
- 12.15 Hangzhou Tigermed
- 12.15.1 Hangzhou Tigermed Company Information
- 12.15.2 Hangzhou Tigermed Business Overview
- 12.15.3 Hangzhou Tigermed Revenue in CROs Services Business (2021-2026)
- 12.15.4 Hangzhou Tigermed CROs Services Product Portfolio
- 12.15.5 Hangzhou Tigermed Recent Developments
- 12.16 EPS International
- 12.16.1 EPS International Company Information
- 12.16.2 EPS International Business Overview
- 12.16.3 EPS International Revenue in CROs Services Business (2021-2026)
- 12.16.4 EPS International CROs Services Product Portfolio
- 12.16.5 EPS International Recent Developments
- 12.17 Courante Oncology
- 12.17.1 Courante Oncology Company Information
- 12.17.2 Courante Oncology Business Overview
- 12.17.3 Courante Oncology Revenue in CROs Services Business (2021-2026)
- 12.17.4 Courante Oncology CROs Services Product Portfolio
- 12.17.5 Courante Oncology Recent Developments
- 12.18 CMIC
- 12.18.1 CMIC Company Information
- 12.18.2 CMIC Business Overview
- 12.18.3 CMIC Revenue in CROs Services Business (2021-2026)
- 12.18.4 CMIC CROs Services Product Portfolio
- 12.18.5 CMIC Recent Developments
- 12.19 Clinipace
- 12.19.1 Clinipace Company Information
- 12.19.2 Clinipace Business Overview
- 12.19.3 Clinipace Revenue in CROs Services Business (2021-2026)
- 12.19.4 Clinipace CROs Services Product Portfolio
- 12.19.5 Clinipace Recent Developments
- 12.20 Charles River Laboratories International Inc (CRL)
- 12.20.1 Charles River Laboratories International Inc (CRL) Company Information
- 12.20.2 Charles River Laboratories International Inc (CRL) Business Overview
- 12.20.3 Charles River Laboratories International Inc (CRL) Revenue in CROs Services Business (2021-2026)
- 12.20.4 Charles River Laboratories International Inc (CRL) CROs Services Product Portfolio
- 12.20.5 Charles River Laboratories International Inc (CRL) Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst